Correlation Between Unity Biotechnology and Abeona Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Abeona Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Abeona Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unity Biotechnology and Abeona Therapeutics, you can compare the effects of market volatilities on Unity Biotechnology and Abeona Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Abeona Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Abeona Therapeutics.
Diversification Opportunities for Unity Biotechnology and Abeona Therapeutics
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Unity and Abeona is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Abeona Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abeona Therapeutics and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Abeona Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abeona Therapeutics has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Abeona Therapeutics go up and down completely randomly.
Pair Corralation between Unity Biotechnology and Abeona Therapeutics
Considering the 90-day investment horizon Unity Biotechnology is expected to generate 2.82 times more return on investment than Abeona Therapeutics. However, Unity Biotechnology is 2.82 times more volatile than Abeona Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Abeona Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 144.00 in Unity Biotechnology on October 24, 2024 and sell it today you would earn a total of 35.00 from holding Unity Biotechnology or generate 24.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unity Biotechnology vs. Abeona Therapeutics
Performance |
| Timeline |
| Unity Biotechnology |
| Abeona Therapeutics |
Unity Biotechnology and Abeona Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unity Biotechnology and Abeona Therapeutics
The main advantage of trading using opposite Unity Biotechnology and Abeona Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Abeona Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will offset losses from the drop in Abeona Therapeutics' long position.| Unity Biotechnology vs. Recursion Pharmaceuticals | Unity Biotechnology vs. Atea Pharmaceuticals | Unity Biotechnology vs. Hookipa Pharma | Unity Biotechnology vs. Acumen Pharmaceuticals |
| Abeona Therapeutics vs. Reviva Pharmaceuticals Holdings | Abeona Therapeutics vs. Athira Pharma | Abeona Therapeutics vs. Fortress Biotech | Abeona Therapeutics vs. ACADIA Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |